Changes in lipid membranes may trigger amyloid toxicity in Alzheimer's disease

被引:77
|
作者
Drolle, Elizabeth [1 ,2 ]
Negoda, Alexander [3 ]
Hammond, Keely [4 ]
Pavlov, Evgeny [3 ,5 ]
Leonenko, Zoya [1 ,2 ,4 ]
机构
[1] Univ Waterloo, Dept Biol, Waterloo, ON, Canada
[2] Univ Waterloo, Waterloo Inst Nanotechnol, Waterloo, ON, Canada
[3] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada
[4] Univ Waterloo, Dept Phys & Astron, Waterloo, ON, Canada
[5] NYU, Coll Dent, Dept Basic Sci, New York, NY USA
来源
PLOS ONE | 2017年 / 12卷 / 08期
基金
加拿大自然科学与工程研究理事会;
关键词
ATOMIC-FORCE MICROSCOPY; BETA-PROTEIN; PEPTIDE; GANGLIOSIDE; CHOLESTEROL; AGGREGATION; MECHANISMS; FIBRILS; DOMAINS; FIBRILLOGENESIS;
D O I
10.1371/journal.pone.0182194
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Amyloid-beta peptides (A beta), implicated in Alzheimer's disease (AD), interact with the cellular membrane and induce amyloid toxicity. The composition of cellular membranes changes in aging and AD. We designed multi-component lipid models to mimic healthy and diseased states of the neuronal membrane. Using atomic force microscopy (AFM), Kelvin probe force microscopy (KPFM) and black lipid membrane (BLM) techniques, we demonstrated that these model membranes differ in their nanoscale structure and physical properties, and interact differently with A beta(1-42). Based on our data, we propose a new hypothesis that changes in lipid membrane due to aging and AD may trigger amyloid toxicity through electrostatic mechanisms, similar to the accepted mechanism of antimicrobial peptide action. Understanding the role of the membrane changes as a key activating amyloid toxicity may aid in the development of a new avenue for the prevention and treatment of AD.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Oligodendrocytes damage in Alzheimer's disease:: Beta amyloid toxicity and inflammation
    Roth, AD
    Ramírez, G
    Alarcón, R
    von Bernhardi, R
    BIOLOGICAL RESEARCH, 2005, 38 (04) : 381 - 387
  • [22] Pathological Changes Induced by Amyloid-β in Alzheimer's Disease
    Takata, Kazuyuki
    Kitamura, Yoshihisa
    Taniguchi, Takashi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (01): : 3 - 11
  • [23] Amyloid cytotoxicity depends on membrane lipid composition in Alzheimer's disease
    Nacmias, B.
    Evangelisti, E.
    Cascella, R.
    Bagnoli, S.
    Sorbi, S.
    Cecchi, C.
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 41 : S35 - S35
  • [24] Metabolite-initiated protein misfolding may trigger Alzheimer's disease
    Zhang, QH
    Powers, ET
    Nieva, J
    Huff, ME
    Dendle, MA
    Bieschke, J
    Glabe, CG
    Eschenmoser, A
    Wentworth, P
    Lerner, RA
    Kelly, JW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (14) : 4752 - 4757
  • [25] Calcium Signaling and Amyloid Toxicity in Alzheimer Disease
    Demuro, Angelo
    Parker, Ian
    Stutzmann, Grace E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (17) : 12463 - 12468
  • [26] Amyloid β-Protein Toxicity and the Pathogenesis of Alzheimer Disease
    Yankner, Bruce A.
    Lu, Tao
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (08) : 4754 - 4758
  • [27] Phosphorylation of amyloid beta (Aβ) peptides - A trigger for formation of toxic aggregates in Alzheimer's disease
    Kumar, Sathish
    Walter, Jochen
    AGING-US, 2011, 3 (08): : 803 - 812
  • [28] In vivo mapping of amyloid toxicity in Alzheimer disease
    Frisoni, G. B.
    Lorenzi, M.
    Caroli, A.
    Kemppainen, N.
    Nagren, K.
    Rinne, J. O.
    NEUROLOGY, 2009, 72 (17) : 1504 - 1511
  • [29] Dendritic changes in Alzheimer's disease and factors that may underlie these changes
    Anderton, BH
    Callahan, L
    Coleman, P
    Davies, P
    Flood, D
    Jicha, GA
    Ohm, T
    Weaver, C
    PROGRESS IN NEUROBIOLOGY, 1998, 55 (06) : 595 - 609
  • [30] Cholesterol modulates beta-amyloid effects on human brain membranes - Specific changes in Alzheimer's disease
    Eckert, GP
    Maras, A
    Gattaz, WF
    Cairns, NJ
    Muller, WE
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 342 - 342